Browsing: category: Movers
Dogecoin And Shiba Inu Sink 7%, But Year’s Best-Performing Cat-Themed Crypto, Popcat, Keeps Head Above Water – Emeren Group (NYSE:SOL)
Cat-themed memecoin Popcat (POPCAT) was the outlier Tuesday, trading in the green amid a broader memecoin meltdown precipitated by fears…
Alibaba Group Holding Limited BABA, also known as China’s tech barometer, continued to trade higher on Monday as China shared…
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio? – Global Payments (NYSE:GPN), Super Micro Computer (NASDAQ:SMCI), Regeneron Pharmaceuticals (NASDAQ:REGN)
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? Summit Therapeutics SMMT…
China’s latest economic stimulus is creating significant ripples in global markets. Following a series of bold actions by the People’s…
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket – Establishment Labs Hldgs (NASDAQ:ESTA)
Shares of Establishment Labs Holdings Inc. ESTA rose sharply in today’s pre-market as the company received U.S. FDA approval for…
What’s Going On With Nvidia, Broadcom, Intel, And Other Chip Stocks On Thursday? – NVIDIA (NASDAQ:NVDA)
Semiconductor stocks especially linked to artificial intelligence led by Nvidia Corp NVDA, Advanced Micro Devices, Inc AMD, Intel Corp INTC,…
Motorsport Games Inc. MSGM shares are trading higher in extended trading Tuesday after the company announced it released the September…
Mullen Automotive, Inc. MULN shares continue to slide Tuesday despite corporate updates from CEO David Michery. The Details: Michery is…
Tesla, Inc. TSLA shares moved higher Monday as investors anticipate the company’s third-quarter delivery figures and the release of its…
IDEAYA Trades Down As Eye Cancer Treatment Shows Promise – IDEAYA Biosciences (NASDAQ:IDYA), Pfizer (NYSE:PFE)
Ideaya Biosciences Inc. IDYA, a precision medicine oncology company, released interim Phase 2 clinical trial data. The data centers on darovasertib…